Castlight Health Inc (NYSE:CSLT) has been given an average rating of “Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $4.81.

Several brokerages have recently weighed in on CSLT. Cantor Fitzgerald reiterated a “buy” rating and set a $5.00 price target on shares of Castlight Health in a research report on Friday, August 17th. Chardan Capital cut Castlight Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $6.00 to $4.80 in a research report on Tuesday, July 31st. Canaccord Genuity decreased their price target on Castlight Health from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Tuesday, July 31st. ValuEngine cut Castlight Health from a “buy” rating to a “hold” rating in a research report on Monday, July 30th. Finally, William Blair reiterated a “buy” rating on shares of Castlight Health in a research report on Thursday, October 18th.

Shares of Castlight Health stock opened at $2.49 on Thursday. Castlight Health has a 52-week low of $2.20 and a 52-week high of $5.95. The stock has a market capitalization of $381.46 million, a P/E ratio of -9.58 and a beta of 1.09. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.02.

Castlight Health (NYSE:CSLT) last announced its quarterly earnings data on Tuesday, November 6th. The software maker reported ($0.01) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.06. Castlight Health had a negative return on equity of 16.59% and a negative net margin of 29.23%. The business had revenue of $40.04 million for the quarter, compared to analysts’ expectations of $38.11 million. During the same period in the previous year, the business posted ($0.05) EPS. The firm’s quarterly revenue was up 16.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Castlight Health will post -0.23 EPS for the current year.

In other news, CFO Mangini Siobhan Nolan sold 13,997 shares of the company’s stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $2.62, for a total transaction of $36,672.14. Following the sale, the chief financial officer now directly owns 192,058 shares in the company, valued at $503,191.96. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO John C. Doyle sold 18,519 shares of the company’s stock in a transaction dated Monday, November 19th. The shares were sold at an average price of $2.69, for a total value of $49,816.11. Following the sale, the chief executive officer now owns 268,523 shares in the company, valued at $722,326.87. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 72,849 shares of company stock worth $193,042. Company insiders own 22.58% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Teachers Advisors LLC increased its position in shares of Castlight Health by 20.8% in the third quarter. Teachers Advisors LLC now owns 168,614 shares of the software maker’s stock worth $455,000 after purchasing an additional 29,078 shares during the last quarter. AQR Capital Management LLC bought a new position in shares of Castlight Health in the third quarter worth approximately $1,030,000. Jane Street Group LLC bought a new position in shares of Castlight Health in the third quarter worth approximately $167,000. Dynamic Technology Lab Private Ltd bought a new position in shares of Castlight Health in the third quarter worth approximately $136,000. Finally, Gagnon Securities LLC increased its position in shares of Castlight Health by 35.8% in the third quarter. Gagnon Securities LLC now owns 2,606,703 shares of the software maker’s stock worth $7,038,000 after purchasing an additional 687,428 shares during the last quarter. Hedge funds and other institutional investors own 53.41% of the company’s stock.

About Castlight Health

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.

Featured Story: Cost of Debt

Analyst Recommendations for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.